Elisabeth J Walsby^1*, Saman Hewamana^1*, Alan Burnett^1*, Steven Knapper¹, Chris Fegan^2* and Chris Pepper^1*

¹Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom
²Cardiff and Vale NHS Trust, Cardiff, United Kingdom

Eva Alvarez^*, Esther Moga^*, Jorge Sierra and Javier Briones^*

Clinical Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain

Davide Del Prete^1*, Shibing Yu, PhD^1*, Guozhi Xiao, PhD^1*, David Roodman, MD, PhD¹ and Sonia D'Souza, PhD^2*

¹Medicine/Hem-Onc., University of Pittsburgh, Pittsburgh, PA
²Medicine, University of Pittsburgh, Pittsburgh, PA

Xiaoming Li, PhD^1*, Tabitha E Wood, PhD^1*, Remco Sprangers, PhD^2*, Xinliang Mao, PhD^1*, Xiaoming Wang, PhD^1*, Yi Zhang, BSc^1*, David Rose, PhD^1*, Robert A. Batey, PhD^3*, Lewis E. Kay, PhD^2* and Aaron D. Schimmer, MD, PhD¹

¹Princess Margaret Hospital, Toronto, ON, Canada
²Departments of Medical Genetics, Biochemistry, and Chemistry, University of Toronto, Toronto, ON, Canada
³Department of Chemistry, University of Toronto, Toronto, ON

Paolo Lunghi^1*, Laura Mazzera^1*, Guerino Lombardi^2*, Micaela Ricca^2*, Attilio Corradi^3*, Anna Maria Cantoni^3*, Nicola Giuliani⁴, Luigi Salvatore^1*, Roberta Riccioni^5*, Antonio Costanzo^6*, Ugo Testa^5*, Massimo Levrero^7*, Vittorio Rizzoli^4* and Antonio Bonati⁸

¹Clinical Sciences, University of Parma, Parma, Italy
²Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, Brescia, Italy
³Animal Health, University of Parma, Parma, Italy
⁴Hematology, University of Parma, Parma, Italy
⁵Italian Institute of Public Health, Rome, Italy
⁶Dermatology, University of Rome "Tor Vergata", Rome, Italy
⁷Internal Medicine, University of Rome "La Sapienza", Rome, Italy
⁸Clinical Sciences and Hematology, University of Parma, Parma, Italy

Emmanuelle Ménoret^*, Sylvanie Surget^*, Patricia Gomez-Bougie^*, Régis Bataille^*, Martine Amiot^* and Catherine Pellat-Deceunynck

Nantes Angers Cancer Center, INSERM U892, Nantes, France

Beth M. Hovey^*, Jennifer Ward^* and David C. Seldin^*

Hematology Oncology, Boston University School of Medicine, Boston, MA

Felix Meinel^1*, Sonja Mandl-Weber^1*, Philipp Baumann^1*, Johann Leban^2* and Ralf Schmidmaier^1*

¹Department of Hematology and Oncology, Medizinische Klinik Innenstadt der Universität München (LMU), Munich, Germany
²4SC AG, Martinsried, Germany

Hiroshi Ikeda, MD, PhD¹, Teru Hideshima, MD, PhD^1*, Robert J. Lutz^2*, Sonia Vallet^1*, Samantha Pozzi, MD^3*, Loredana Santo^1*, Elisabetta Calabrese^1*, Benjamin Dälken^4*, Christoph Uherek^4*, Silke Aigner^4*, Frank Osterroth^4*, Mariateresa Fultiniti^1*, Yutaka Okawa^1*, Giulia Perrone^1*, Gullu Gorgun^1*, Hiroshi Yasui^5*, Diana Cristia^1*, Noopur Raje, MD^1*, Nikhil Munshi, MD^1*, Paul Richardson, MD^1* and Kenneth C. Anderson, MD^1*

¹Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²ImmunoGen Inc., Waltham, MA
³Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁴Biotest AG, Dreieich,, Germany
⁵First department of internal medisine, Sapporo medical university, Sapporo, Japan

Yutaka Hattori¹, Shin-ichiro Okamoto, MD, PhD², Wenlin Du^3*, Taketo Yamada^3*, Naoki Shimada^4*, Kunio Matsumoto^5*, Morihiko Sagawa^2* and Yasuo Ikeda^2*

¹Clinical physiology and therapeutics, Keio University Faculty of Pharmacy, Tokyo, Japan
²Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
³Pathology, Keio University School of Medicine, Tokyo, Japan
⁴Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan
⁵Cancer Research Institute, Kanazawa University, Kanazawa, Japan

Toshihiko Ishii^1*, Asher Alban Chanan-Khan, MD², Jazur Jafferjee, MD^2*, Noreen Ersing^2*, Takeshi Takahashi, PhD^1*, Masato Mizutani, PhD^1*, Yukimasa Shiotsu, PhD¹ and Nobuo Hanai, PhD^1*

¹Oncology Group, Fuji Research Park, Kyowa Hakko Kirin Co., Ltd, Shizuoka, Japan
²Roswell Park Cancer Inst., Buffalo, NY

Gullu Gorgun, PhD¹, Elisabetta Calabrese, MD^1*, Mala Mani, PhD^1*, Teru Hideshima, M.D., Ph.D.², Hiroshi Ikeda, MD, PhD¹, Giulia Perrone, MD^1*, Loredana Santo, MD^1*, Diana Cirstea, MD^1*, Simona Blotta¹, Paul G. Richardson, MD^1*, Jeffrey Ecsedy^3* and Kenneth C. Anderson, MD¹

¹Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
³Millenium Pharmaceuticals, Cambridge, MA

Julia Schüler^1*, Dagmar Wider^2*, Dietmar Pfeifer^2*, Martin Wagner^1*, Heinz-Herbert Fiebig^1* and Monika Engelhardt²

¹Oncotest GmbH, Freiburg, Germany
²Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany

Norioki Ohno, MD^1*, Teruyuki Kajiume, MD, PhD^2*, Yoshihiko Sera, MD, PhD^1*, Takashi Sato, MD, PhD^3* and Masao Kobayashi, MD, PhD⁴

¹Pediatrics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan
²Pediatrics, Hiroshima University Graduate School of Biomedical Sciencies, Hiroshima, Japan
³Pediatrics, Hiroshima University Graduate School of Biomedical, Hiroshima, Japan
⁴Hiroshima University, Hiroshima, Japan

Mark van Duin^1*, Surinder S. Sahota^2*, Yvonne de Knegt^1*, Annemiek Broyl^1*, Debora Joseph-Pietras^2*, George Mulligan^3*, Barb Bryant^3* and Pieter Sonneveld¹

¹Hematology, Erasmus Medical Center Rotterdam, Rotterdam, Netherlands
²Molecular Immunology group, Tenovus Laboratory, Southampton University Hospital, Southampton, United Kingdom
³Millennium Pharmaceuticals, Cambridge